Quest Diagnostics 第三季度利润超出预期;在新客户和合作伙伴关系的推动下，收入同比增长 8.5%。 Quest Diagnostics Q3 profit beats estimates; revenue up 8.5% YoY, driven by new customers and partnerships.
Quest Diagnostics Inc. 报告称，第三季度每股收益为 2.30 美元，超出预期，销售额达到 24.9 亿美元，均高于分析师的预期。 Quest Diagnostics Inc. reported Q3 earnings of $2.30 per share, surpassing expectations, with sales reaching $2.49 billion—both higher than analyst estimates. 新的客户采购和扩大伙伴关系推动的收入逐年增长8.5%。 Revenue grew 8.5% year-over-year, driven by new customer acquisitions and expanded partnerships. 该公司现在预测2024年的收入在98亿至98.5亿美元之间,调整后的EPS为885美元至895美元。 The company now forecasts 2024 revenue between $9.80 billion and $9.85 billion and adjusted EPS of $8.85 to $8.95. 包括 " 生命实验室 " 在内的近期收购促成了这一乐观前景。 Recent acquisitions, including LifeLabs, contributed to this optimistic outlook.